Table 1.
PDE isoform* | rolipram IC50/% inh. | 6 IC50/% inh. | |
---|---|---|---|
rolipram |
PDE1A | inactive | inactive |
PDE1B | inactive | inactive | |
PDE1C | inactive | 26% | |
PDE2A | inactive | 41% | |
6 (NCGC00165289) |
PDE3A | inactive | 1.7 μM |
PDE3B | inactive | 720 nM | |
PDE4A1A | 102 nM | 12.9 nM | |
PDE4B1 | 901 nM | 48.2 nM | |
PDE4B2 | 534 nM | 37.2 nM | |
PDE4C1 | 40% | 452 nM | |
PDE4D2 | 403 nM | 49.2 nM | |
PDE5A1 | inactive | 60% | |
PDE7A | inactive | 73% | |
PDE7B | inactive | 33% | |
PDE8A1 | inactive | 57% | |
PDE9A2 | inactive | inactive | |
PDE10A1 | inactive | 823 nM | |
PDE11A4 | inactive | inactive |
data generated by BPS Biosciences (CA) [http://www.bpsbioscience.com] and represents either the IC50 value or the % inhibition at 10 uM of compound.